HeartFlow NovoCure: Which Emerging Stock Is Best in 2026
HeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
Which Sectors Lead Indices During Earnings Season examines which sectors typically drive index gains or losses, guiding allocation decisions.
26,374 articlesHeartFlow and NovoCure represent two very different paths to modernizing care. One targets non invasive CAD diagnosis...
Verizon raises its dividend with a high yield, while Johnson & Johnson offers steadier growth and a long payout histo...
Two U.S. startups, Archer Aviation and Joby Aviation, are racing to pioneer urban air mobility. This guide breaks dow...
In 2026, two very different healthcare players—Abbott Laboratories and Glaukos—offer contrasting paths to potential g...
A colossal AI infrastructure agreement links Meta Platforms with Nebius in a five-year plan worth $27 billion. This a...
A new PWBM study places the insolvency deadline for Social Security's trust fund at 2032, six years from now. It eval...
XPeng reported a rare quarterly profit in Q4 2025 but warned of a softer start to 2026, sending shares lower as inves...
Circle stock surged after first-quarter results beat expectations and a fresh Arc funding round. This Morning Minute ...
Two AI bets with very different risk profiles surfaced as Microsoft and Palantir reported earnings. Microsoft leans o...
A shift in AI hardware could redefine winners and losers in tech investing. Here’s how ASICs may outpace GPUs and whi...
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Anthropic's IPO signals more than one company going public. It underscores a rising demand for AI compute, potentiall...